Massachusetts Blue Cross Blue Shield of Massachusetts, operating within the Anthem corporate family, ended obesity medication coverage effective January 1, 2026
Furthermore, the review explores novel drug delivery strategies, such as microsphere encapsulation, injectable hydrogels, Fc-fusion, and oral small-molecule formulations, aimed at achieving sustained and controlled release to reduce dosing frequency and improve patient compliance
Early doses are often used to help the body adjust, so they may not produce the same effect as later therapeutic doses
, Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis, Clin
To extract maximum benefit from decelerated stomach pacing, consume well-rounded meals with protein, fiber, and healthy fats
Horneff said more research is needed to understand why GLP-1 drugs might affect bone health